Characterizing Treatment Utilization Patterns for Trigeminal Neuralgia in the United States

Conclusions: In the 3 years after diagnosis, patients with TN in the United States receive a variety of pharmacological treatments, including opioids, despite carbamazepine being the only approved medication. A notable proportion utilize surgeries/injections. A high proportion of pharmacologically treated patients receive multiple treatment episodes, suggesting frequent therapy switching, perhaps because of suboptimal efficacy/tolerability. Our data suggest a high burden of illness associated with TN.
Source: The Clinical Journal of Pain - Category: Anesthesiology Tags: Original Articles Source Type: research